381 related articles for article (PubMed ID: 30343257)
1. Neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response.
Bennett C; Mohammed F; Álvarez-Ciara A; Nguyen MA; Dietrich WD; Rajguru SM; Streit WJ; Prasad A
Biomaterials; 2019 Jan; 188():144-159. PubMed ID: 30343257
[TBL] [Abstract][Full Text] [Related]
2. Blood brain barrier (BBB)-disruption in intracortical silicon microelectrode implants.
Bennett C; Samikkannu M; Mohammed F; Dietrich WD; Rajguru SM; Prasad A
Biomaterials; 2018 May; 164():1-10. PubMed ID: 29477707
[TBL] [Abstract][Full Text] [Related]
3. The complement cascade at the Utah microelectrode-tissue interface.
Bennett C; Álvarez-Ciara A; Franklin M; Dietrich WD; Prasad A
Biomaterials; 2021 Jan; 268():120583. PubMed ID: 33310540
[TBL] [Abstract][Full Text] [Related]
4. BBB leakage, astrogliosis, and tissue loss correlate with silicon microelectrode array recording performance.
Nolta NF; Christensen MB; Crane PD; Skousen JL; Tresco PA
Biomaterials; 2015; 53():753-62. PubMed ID: 25890770
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.
Banks WA; Gray AM; Erickson MA; Salameh TS; Damodarasamy M; Sheibani N; Meabon JS; Wing EE; Morofuji Y; Cook DG; Reed MJ
J Neuroinflammation; 2015 Nov; 12():223. PubMed ID: 26608623
[TBL] [Abstract][Full Text] [Related]
6. Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage.
Li Y; Yang H; Ni W; Gu Y
PLoS One; 2017; 12(3):e0172784. PubMed ID: 28249040
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury.
Lee JY; Keep RF; He Y; Sagher O; Hua Y; Xi G
J Cereb Blood Flow Metab; 2010 Nov; 30(11):1793-803. PubMed ID: 20736956
[TBL] [Abstract][Full Text] [Related]
8. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.
Nakamura T; Keep RF; Hua Y; Schallert T; Hoff JT; Xi G
Neurosurg Focus; 2003 Oct; 15(4):ECP4. PubMed ID: 15344903
[TBL] [Abstract][Full Text] [Related]
9. Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia.
Chi OZ; Hunter C; Liu X; Weiss HR
Neurol Res; 2008 Apr; 30(3):288-93. PubMed ID: 17767813
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic hypothermia reduces cortical inflammation associated with utah array implants.
Dugan EA; Bennett C; Tamames I; Dietrich WD; King CS; Prasad A; Rajguru SM
J Neural Eng; 2020 Apr; 17(2):026035. PubMed ID: 32240985
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of cathepsin B/D and caspase-3 in deferoxamine-related neuroprotection of early brain injury after subarachnoid haemorrhage in rats.
Yu ZQ; Jia Y; Chen G
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):270-83. PubMed ID: 24117543
[TBL] [Abstract][Full Text] [Related]
12. Deferoxamine inhibits microglial activation, attenuates blood-brain barrier disruption, rescues dendritic damage, and improves spatial memory in a mouse model of microhemorrhages.
He XF; Lan Y; Zhang Q; Liu DX; Wang Q; Liang FY; Zeng JS; Xu GQ; Pei Z
J Neurochem; 2016 Aug; 138(3):436-47. PubMed ID: 27167158
[TBL] [Abstract][Full Text] [Related]
13. Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction.
Nzou G; Wicks RT; VanOstrand NR; Mekky GA; Seale SA; El-Taibany A; Wicks EE; Nechtman CM; Marrotte EJ; Makani VS; Murphy SV; Seeds MC; Jackson JD; Atala AJ
Sci Rep; 2020 Jun; 10(1):9766. PubMed ID: 32555384
[TBL] [Abstract][Full Text] [Related]
14. The impact of chronic blood-brain barrier breach on intracortical electrode function.
Saxena T; Karumbaiah L; Gaupp EA; Patkar R; Patil K; Betancur M; Stanley GB; Bellamkonda RV
Biomaterials; 2013 Jul; 34(20):4703-13. PubMed ID: 23562053
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial ferritin upregulation reduced oxidative stress and blood-brain-barrier disruption by maintaining cellular iron homeostasis in a neonatal rat model of germinal matrix hemorrhage.
Yuan Y; He Q; Yang X; Flores JJ; Huang L; Luo X; Zhang X; Zhang Z; Li R; Gu L; Dong S; Zhu S; Yi K; Han M; Wu L; Zhou Y; Zhang JH; Xie Z; Tang J
Exp Neurol; 2024 Apr; 374():114703. PubMed ID: 38281588
[TBL] [Abstract][Full Text] [Related]
16. Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine.
Moraes LH; de Burgos RR; Macedo AB; de Almeida Hermes T; de Faria FM; Minatel E
Biol Trace Elem Res; 2015 Sep; 167(1):115-20. PubMed ID: 25762099
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
Teixeira KC; Soares FS; Rocha LG; Silveira PC; Silva LA; Valença SS; Dal Pizzol F; Streck EL; Pinho RA
Pulm Pharmacol Ther; 2008; 21(2):309-16. PubMed ID: 17904883
[TBL] [Abstract][Full Text] [Related]
18. Activation of inflammasomes and their effects on neuroinflammation at the microelectrode-tissue interface in intracortical implants.
Franklin ME; Bennett C; Arboite M; Alvarez-Ciara A; Corrales N; Verdelus J; Dietrich WD; Keane RW; de Rivero Vaccari JP; Prasad A
Biomaterials; 2023 Jun; 297():122102. PubMed ID: 37015177
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components.
Alikunju S; Abdul Muneer PM; Zhang Y; Szlachetka AM; Haorah J
Brain Behav Immun; 2011 Jun; 25 Suppl 1(Suppl 1):S129-36. PubMed ID: 21262340
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury.
van Vliet EA; Ndode-Ekane XE; Lehto LJ; Gorter JA; Andrade P; Aronica E; Gröhn O; Pitkänen A
Neurobiol Dis; 2020 Nov; 145():105080. PubMed ID: 32919030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
